Literature DB >> 7829677

Post-infantile giant cell hepatitis: histological and immunohistochemical study.

S J Johnson1, J Mathew, R N MacSween, M K Bennett, A D Burt.   

Abstract

AIM: To determine the composition of the inflammatory infiltrate and to check for the presence of cytomegalovirus (CMV) and Epstein-Barr virus (EBV) in nine cases of post-infantile giant cell hepatitis.
METHODS: The clinical, serological, and histological features of the nine cases were reviewed. Immunohistochemistry was used on liver biopsy specimens from six cases to: (i) characterise the lymphocytic infiltrate; (ii) assess the monocyte/macrophage response; (iii) detect "activated" perisinusoidal cells; and (iv) detect CMV and EBV antigens. Electron microscopic examination was carried out in two cases.
RESULTS: Four patients had serological features suggestive of autoimmune chronic active hepatitis; in the other five cases the aetiology was obscure. Two patients presented with neurological symptoms. Hepatitis resolved completely in one patient; two patients showed clinical improvement; and one remained stable. Cirrhosis developed in three patients, one of whom proceeded to liver transplantation, and three patients died. Portal inflammation was present in all cases and lymphocytic piecemeal necrosis in eight cases, but intra-acinar inflammation associated with hepatocyte necrosis was observed in only five cases. The inflammatory infiltrate was composed predominantly of T lymphocytes; an increase in monocyte/macrophage cells was also observed. Mallory bodies, often with associated neutrophilic infiltrate, were present in four cases, and bilirubinostasis was a feature in four cases. "Activated" perisinusoidal cells were present, especially in relation to areas of inflammation, necrosis, and fibrosis. There was severe fibrosis or cirrhosis in five cases. Paramyxoviral nucleocapsids were not seen in the two cases examined ultrastructurally.
CONCLUSIONS: Post-infantile giant cell hepatitis should be viewed as a heterogeneous clinical and aetiological entity encompassing cases of hepatitis with extensive giant cell hepatocyte transformation.

Entities:  

Mesh:

Year:  1994        PMID: 7829677      PMCID: PMC503066          DOI: 10.1136/jcp.47.11.1022

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  19 in total

1.  Hepatitis in association with prolonged 6-mercaptopurine therapy.

Authors:  S K McILVANIE; J D MACCARTHY
Journal:  Blood       Date:  1959-01       Impact factor: 22.113

2.  Isolation of measles virus at autopsy in cases of giant-cell pneumonia without rash.

Authors:  J F ENDERS; K McCARTHY; A MITUS; W J CHEATHAM
Journal:  N Engl J Med       Date:  1959-10-29       Impact factor: 91.245

3.  Postinfantile giant-cell transformation in hepatitis.

Authors:  K Devaney; Z D Goodman; K G Ishak
Journal:  Hepatology       Date:  1992-08       Impact factor: 17.425

4.  Giant multinucleated hepatocytes in an adult with chronic active hepatitis.

Authors:  J Richey; S Rogers; D H Van Thiel; R Lester
Journal:  Gastroenterology       Date:  1977-09       Impact factor: 22.682

5.  Ultrastructural studies in giant cell transformation of the liver.

Authors:  B Elsner
Journal:  Medicina (B Aires)       Date:  1973 May-Jun       Impact factor: 0.653

6.  Cirrhosis associated with methotrexate treatment of psoriasis.

Authors:  R O Coe; F E Bull
Journal:  JAMA       Date:  1968-11-11       Impact factor: 56.272

7.  Post-infantile giant cell hepatitis.

Authors:  H Thaler
Journal:  Liver       Date:  1982-12

8.  Chronic active hepatitis and giant multinucleated hepatocytes in adults treated with clometacin.

Authors:  D Pessayre; F Degos; G Feldmann; C Degott; J Bernuau; J P Benhamou
Journal:  Digestion       Date:  1981       Impact factor: 3.216

9.  Syncytial giant-cell hepatitis. Sporadic hepatitis with distinctive pathological features, a severe clinical course, and paramyxoviral features.

Authors:  M J Phillips; L M Blendis; S Poucell; J offterson; M Petric; E Roberts; G A Levy; R A Superina; P D Greig; R Cameron
Journal:  N Engl J Med       Date:  1991-02-14       Impact factor: 91.245

10.  HIV as a cause of giant cell hepatitis.

Authors:  C L Witzleben; G S Marshall; W Wenner; D A Piccoli; S D Barbour
Journal:  Hum Pathol       Date:  1988-05       Impact factor: 3.466

View more
  12 in total

1.  Sinus histiocytosis with massive lymphadenopathy and giant cell hepatitis. An unreported association.

Authors:  Dimas Suarez-Vilela; Francisco Miguel Izquierdo-Garcia; José Luis Olcoz-Goñi
Journal:  Virchows Arch       Date:  2003-11-18       Impact factor: 4.064

2.  Giant cell hepatitis associated with systemic lupus erythematosus.

Authors:  A Cairns; R F McMahon
Journal:  J Clin Pathol       Date:  1996-02       Impact factor: 3.411

3.  Postinfantile giant cell hepatitis due to hepatitis E virus along with the presence of autoantibodies.

Authors:  Ozgür Harmanci; Ibrahim Koral Onal; Osman Ersoy; Bora Gürel; Cenk Sökmensüer; Yusuf Bayraktar
Journal:  Dig Dis Sci       Date:  2007-04-05       Impact factor: 3.199

4.  Giant-cell Hepatitis-Rare Entity in Adults.

Authors:  Shiran Shetty; Krishnaveni Janarthanan; Venkatakrishnan Leelakrishnan; Vadakkepat Nirmala
Journal:  J Clin Exp Hepatol       Date:  2016-03-04

5.  Hepatitis - A induced Non Infantile Giant Cell Hepatitis.

Authors:  P Kinra; B M John
Journal:  Med J Armed Forces India       Date:  2011-07-21

6.  Giant cell hepatitis in adults.

Authors:  L Gábor; K Pál; S Zsuzsa
Journal:  Pathol Oncol Res       Date:  1997-09       Impact factor: 3.201

7.  Syncytial giant cell hepatitis associated with chronic lymphocytic leukemia: a case report.

Authors:  Eva Gupta; Michael Yacoub; Martha Higgins; Ayad M Al-Katib
Journal:  BMC Blood Disord       Date:  2012-07-19

8.  Postinfantile giant cell hepatitis: an etiological and prognostic perspective.

Authors:  Chhagan Bihari; Archana Rastogi; Shiv Kumar Sarin
Journal:  Hepat Res Treat       Date:  2013-03-11

Review 9.  The potential of cell fusion for human therapy.

Authors:  Stephen Sullivan; Kevin Eggan
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 6.692

10.  Postinfantile Giant Cell Hepatitis with Features of Acute Severe Autoimmune Hepatitis Probably Triggered by Diclofenac in a Patient with Primary Myelofibrosis.

Authors:  Pinelopi Arvaniti; Kalliopi Zachou; George K Koukoulis; George N Dalekos
Journal:  Case Reports Hepatol       Date:  2018-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.